BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Key Financial Ratios of Thyrocare Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 15.02 | 17.84 | 17.91 | 8.69 | 11.42 | |
| Diluted EPS (Rs.) | 14.99 | 17.80 | 17.85 | 8.69 | 11.41 | |
| Cash EPS (Rs.) | 18.71 | 20.78 | 20.13 | 10.86 | 13.05 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 71.58 | 86.32 | 84.48 | 77.80 | 69.87 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 71.58 | 86.32 | 84.48 | 77.80 | 69.87 | |
| Dividend / Share(Rs.) | 5.00 | 20.00 | 10.00 | 10.00 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 75.90 | 70.13 | 61.76 | 55.38 | 43.77 | |
| PBDIT/Share (Rs.) | 33.53 | 30.64 | 30.27 | 23.48 | 18.58 | |
| PBIT/Share (Rs.) | 29.84 | 27.90 | 28.02 | 21.30 | 16.47 | |
| PBT/Share (Rs.) | 21.20 | 27.81 | 27.54 | 16.15 | 16.52 | |
| Net Profit/Share (Rs.) | 15.01 | 18.04 | 17.88 | 8.69 | 10.94 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 44.18 | 43.69 | 49.01 | 42.39 | 42.44 | |
| PBIT Margin (%) | 39.30 | 39.78 | 45.37 | 38.46 | 37.62 | |
| PBT Margin (%) | 27.92 | 39.66 | 44.59 | 29.15 | 37.74 | |
| Net Profit Margin (%) | 19.77 | 25.71 | 28.94 | 15.68 | 24.98 | |
| Return on Networth / Equity (%) | 20.97 | 20.89 | 21.15 | 11.16 | 15.65 | |
| Return on Capital Employed (%) | 40.25 | 31.34 | 20.56 | 26.71 | 22.96 | |
| Return on Assets (%) | 17.92 | 19.52 | 19.78 | 10.50 | 14.17 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 90.65 | 75.90 | 68.36 | 66.98 | 56.73 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.24 | 6.29 | 7.53 | 9.74 | 3.98 | |
| Quick Ratio (X) | 1.88 | 5.41 | 6.63 | 8.87 | 3.64 | |
| Inventory Turnover Ratio (X) | 21.69 | 23.80 | 20.14 | 21.62 | 23.78 | |
| Dividend Payout Ratio (NP) (%) | 166.41 | 28.21 | 55.94 | 86.33 | 87.36 | |
| Dividend Payout Ratio (CP) (%) | 133.52 | 24.49 | 49.68 | 69.04 | 73.22 | |
| Earnings Retention Ratio (%) | -66.41 | 71.79 | 44.06 | 13.67 | 12.64 | |
| Cash Earnings Retention Ratio (%) | -33.52 | 75.51 | 50.32 | 30.96 | 26.78 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,611.19 | 2,791.99 | 3,220.34 | 3,834.41 | 0.00 | |
| EV/Net Operating Revenue (X) | 6.51 | 7.54 | 9.71 | 12.89 | 0.00 | |
| EV/EBITDA (X) | 14.74 | 17.26 | 19.80 | 30.40 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 6.53 | 7.56 | 9.73 | 12.92 | 0.00 | |
| Retention Ratios (%) | -66.41 | 71.78 | 44.05 | 13.66 | 12.63 | |
| Price/BV (X) | 6.92 | 6.15 | 7.12 | 9.20 | 0.00 | |
| Price/Net Operating Revenue | 6.53 | 7.56 | 9.73 | 12.92 | 0.00 | |
| Earnings Yield | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss